Rocket Pharmaceuticals Inc

NASDAQ:RCKT  
52.39
+2.33 (+4.65%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Rocket Pharmaceuticals, Inc. Stock, NASDAQ:RCKT

The Empire State Building, 350 5th Avenue, New York, New York 10118
United States of America
Phone: +1.646.440.9100
Number of Employees: 57

Description

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm's clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded in 1999 and is headquartered in New York, NY.